NFKB2 and ovarian carcinoma: Therefore, is possible that DDX3X exerts an oncosuppressive role in ovarian cancer by acting on the negative regulation of NFκB2 at different levels by direct interaction with NF-κB or by enhancing the expression of ISG15 that in turn suppresses NFκB2 activity.